These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27678180)

  • 1. Preface.
    Al-Jamal KT
    Int Rev Neurobiol; 2016; 130():xi-xiv. PubMed ID: 27678180
    [No Abstract]   [Full Text] [Related]  

  • 2. Preface.
    Sharma HS
    Int Rev Neurobiol; 2012; 102():xv-xx. PubMed ID: 22748836
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain drug delivery systems.
    Jiang X
    Pharm Res; 2013 Oct; 30(10):2427-8. PubMed ID: 23921487
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
    Dilnawaz F; Sahoo SK
    Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L; Rosch J; Putnam D
    J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood brain barrier in relation to viruses.
    Mosley JW
    JAMA; 1967 Sep; 201(10):769. PubMed ID: 6071887
    [No Abstract]   [Full Text] [Related]  

  • 8. From the Blood to the Central Nervous System: A Nanoparticle's Journey Through the Blood-Brain Barrier by Transcytosis.
    Fullstone G; Nyberg S; Tian X; Battaglia G
    Int Rev Neurobiol; 2016; 130():41-72. PubMed ID: 27678174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood-brain barrier and blood-nerve barrier in neuroinflammatory diseases].
    Maeda T; Kanda T
    Nihon Rinsho; 2013 May; 71(5):789-94. PubMed ID: 23777083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurological disorders and the blood-brain barrier. Strategies and limitations for drug delivery to the brain].
    Domínguez A; Álvarez A; Suárez-Merino B; Goñi-de-Cerio F
    Rev Neurol; 2014 Mar; 58(5):213-24. PubMed ID: 24570360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of P32 for clinical studies of the permeability of the blood-brain barrier].
    Leksin EN
    Med Radiol (Mosk); 1967 May; 12(5):47-50. PubMed ID: 5621326
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymeric nanoparticles - targeted drug delivery systems for treatment of CNS disorders and their possible endocrine disrupting activities.
    Rollerova E; Scsukova S; Jurcovicova J; Mlynarcikova A; Szabova E; Kovriznych J; Zeljenkova D
    Endocr Regul; 2011 Jan; 45(1):49-60. PubMed ID: 21314211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicines for the Treatment of CNS Diseases.
    Reynolds JL; Mahato RI
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
    Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
    Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbance of blood brain barrier in a case of encephalomyelopathy.
    Leins PA; Adams AH; Wanyik G; Bodfish RE
    Bull Los Angeles Neurol Soc; 1970 Apr; 35(2):74-7. PubMed ID: 5439324
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood-brain barrier: recent developments and clinical correlations.
    Benarroch EE
    Neurology; 2012 Apr; 78(16):1268-76. PubMed ID: 22508848
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cerebral vascular permeability. II. Penetration of antibiotics, especially penicillin, into the central nervous system].
    GONSETTE R; ANDRE J
    Acta Neurol Psychiatr Belg; 1959 May; 59(5):562-81. PubMed ID: 13669968
    [No Abstract]   [Full Text] [Related]  

  • 19. [Breakdown of BBB and BNB in neuroimmunological diseases].
    Sano Y; Kanda T
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():50-6. PubMed ID: 26480680
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
    Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
    Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.